Lv21
138 积分 2025-07-14 加入
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis B
9分钟前
已完结
International expert panel review for the use of resmetirom and semaglutide in the management of MASH-related fibrosis: clinical practice update
23天前
已完结
Macrophage functional diversity in NAFLD — more than inflammation
5个月前
已完结
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
5个月前
已完结
Biliary YB-1/GLI2 axis facilitates ductular reaction and promotes HSC activation via SPP1/integrin αvβ1 signaling during liver fibrogenesis
5个月前
已完结
Distinct gut microbiota but common metabolomic signatures between viral and MASLD HCC contribute to outcomes of combination immunotherapy
6个月前
已完结
Use of liver stiffness measurement for HCC risk stratification in metabolic dysfunction–associated steatotic liver disease
6个月前
已完结
An etiology-stratified single-cell atlas identifies FABP4 as a prognostic marker for MASLD-related HCC
6个月前
已完结
A reference map of potential determinants for the human serum metabolome
6个月前
已完结
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study
7个月前
已完结
皖公网安备34019202002308
